Aclaris Rockets 300%, Smashes Targets!
ACRIS (1D TF): Targets Smashed with 300% Gains!
Trade Details:
The long trade setup on the daily timeframe has exceeded expectations, blasting past all profit targets using the Risological Trading Indicator. The stock has delivered an impressive 300% gain, outperforming initial forecasts.
Key Levels:
Take Profit Targets:
Analysis:
This massive rally showcases strong bullish momentum, driven by high market interest. With such a breakout, Aclaris demonstrates its potential as a high-performing asset.
Outlook:
Momentum traders can consider monitoring for retracements or further bullish setups. A stellar move like this reinforces the power of spotting trends early!
Trade Details:
The long trade setup on the daily timeframe has exceeded expectations, blasting past all profit targets using the Risological Trading Indicator. The stock has delivered an impressive 300% gain, outperforming initial forecasts.
Key Levels:
- Entry: 1.20
- Stop Loss (SL): 1.16
Take Profit Targets:
- TP1: 1.25 ✅
- TP2: 1.32 ✅
- TP3: 1.40 ✅
- TP4: 1.45 ✅
Analysis:
This massive rally showcases strong bullish momentum, driven by high market interest. With such a breakout, Aclaris demonstrates its potential as a high-performing asset.
Outlook:
Momentum traders can consider monitoring for retracements or further bullish setups. A stellar move like this reinforces the power of spotting trends early!
- Indicator used on my charts> Risological.com
- Accurate Entry, Stoploss and Take Profit levels on all charts
- NO Repaint!
- Consistent profits
- Detect and avoid Sideways Market
- Works on all markets and all time frames.
- Accurate Entry, Stoploss and Take Profit levels on all charts
- NO Repaint!
- Consistent profits
- Detect and avoid Sideways Market
- Works on all markets and all time frames.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.